Per favore
selezionare il paese

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

Selezionando la visualizzazione internazionale, l'utente dichiara di risiedere al di fuori degli Stati Uniti e di voler visualizzare le informazioni sui prodotti internazionali di DiaSorin Molecular. Questo materiale è destinato esclusivamente ai visitatori internazionali (non statunitensi) del sito.

Ai sensi delle Linee Guida del Ministero della Salute del 28/03/2013 in materia di pubblicità sanitaria relativa a dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici, si informa che le informazioni contenute in questo sito e alle quali si accede sono destinate esclusivamente agli operatori professionali.

VERIGENE^® Enteric Pathogens Test

Help patients recover from gastrointestinal infections more quickly

VERIGENE^® Enteric Pathogens Test is a rapid, easy-to-use, and cost-effective alternative to traditional stool diagnostics that delivers clinical, economic, and workflow benefits.

Test diagnostico Verigene per aiutare i pazienti nel recupore da disturbi gastrointestinali - Diasorin

Disease state

Gastrointestinal infections lead to approximately 500,000 hospitalizations per year and 179 million outpatient visits annually in the U.S. It is the cause of more than 5,000 deaths per year and has become the leading cause of death in children under 5 years of age globally. Additionally, hospital outbreaks can lead to severe illness in at-risk populations and hospital ward closures. Diarrhea can also have a significant impact on society by disrupting daily life activities and leading to a high economic burden.

Gastrointestinal infections are a serious medical condition that can cause illness or death

The value of VERIGENE^® Enteric Pathogens Test (EP)

Empower clinicians to rapidly optimize treatment for enteric pathogens

Proven clinical impact

Rapid identification of enteric pathogens can improve patient management decision-making, thereby minimizing the use of inappropriate drugs.

Outstanding economic value

Decrease costs by reducing the length of stay and minimizing the use of inappropriate antimicrobial drugs.

Workflow benefits

Confirmation of a negative stool sample takes only two hours on the VERIGENE^® System, allowing labs to reallocate tech time to other priorities within the lab.

How the VERIGENE^® Enteric Pathogen Test works

VERIGENE^® EP is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium.

Sample-to-answer

Consumables arrive at the laboratory ready to use with no further reagent preparation.

Faster time to results

Improve laboratory efficiency, increase positivity rate, and reduce turnaround times compared to culture by using VERIGENE^® EP.

Indications for VERIGENE^® Enteric Pathogens Test use

System

For use on the VERIGENE^® system as an aid in the diagnosis of specific agents of gatrointestinal illness